Skip to main content
Premium Trial:

Request an Annual Quote

New Products Posted to GenomeWeb: Qiagen, CareDx, Synthego, More

Qiagen QiaSeq Direct SARS-CoV-2 Kit

Qiagen has launched the QiaSeq Direct SARS-CoV-2 Kit, a viral genome enrichment and library preparation product that the company said significantly reduces library turnaround times and plastics use compared with ARTIC project protocols (primer-based approaches for next-generation sequencing that are considered the gold standard for SARS-CoV-2 genome sequencing). QiaSeq Direct SARS-CoV-2 supports sample multiplexing with up to 768 Dual Molecular Indices, unique markets tagged to molecules in a sample to eliminate downstream analysis errors. Starting from extracted viral RNA, the library prep workflow can be as little as four hours, Qiagen said. In addition, plastics usage can be reduced by as much as 50 percent. Qiagen said the new kit is supported by Qiagen's Digital Insights CoV-2 Insights Service, a cloud-based solution tailored to viral genome analysis, characterization, and reporting.


CareDx European HLA Typing Service

CareDx has launched a research-use-only HLA typing service for customers in Europe out of its next-generation sequencing lab in Stockholm. The CareDx HLA typing service is powered by AlloSeq Tx17 and uses high-resolution hybrid-capture technology to yield a fast turnaround time with no long-range PCR inefficiencies. CareDx said that AlloSeq Tx17 provides over 50 percent more gene content than other commercial NGS solutions, including 11 classical HLA loci as well as HLA-E, -F, -G, -H, MICA, and MICB. A company spokesperson said that the service will be available to customers in the US later this year.


Synthego Eclipse Platform

Synthego has launched Eclipse, a CRISPR-based high-throughput cell engineering platform. The automated platform is cell-type agnostic, optimizes transfection, and provides end-to-end data tracking software. Applications include disease modeling, drug target identification and validation, and cell therapy manufacturing.


For more new products and services, please visit the New Products page on our website.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.